| Value | ₹10.00 Cr |
|---|
BSE filing, BSE: 544412. Summary written from the filing by ALFA Finder's alert engine.
3B Films Ltd: key numbers
- Share price
- ₹14.00
- Market cap
- ₹39.16 Cr
- Revenue (annual)
- ₹60.01 Cr
- Net profit (annual)
- ₹1.84 Cr
- P/E (TTM)
- 21.2×Sector 45.0×
- Promoter holding
- 63.40%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from 3B Films Ltd
All →3B Films Other Announcement
3B Films Ltd declared the Corporate Governance Report non-applicable under Reg 27(2), citing SME listing. No transaction, financial figure, or operational event is involved.
3B Films Management Change
3B Films Ltd has appointed Mr. Raju Dubey as a Non-Executive, Independent Director, effective October 06, 2026.
3B Films Board Meeting Outcome
3B Films Ltd appointed Mr. Raju Dubey as a Non-Executive, Independent Director. The board meeting held on October 06, 2026, approved this appointment.
3B Films Management Change
3B Films appointed an Independent Director and new Company Secretary at its September 2026 board meeting. These appointments strengthen board governance and compliance infrastructure.
3B Films Price Movement Clarification
3B Films Ltd clarified that recent stock price movements were market-driven, stating they have no undisclosed information impacting the share price.
3B Films Other Announcement
3B Films Limited has updated its Corporate Identification Number (CIN) on the MCA portal following its recent stock exchange listing.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr